flow trial semaglutide kidney outcomes 2024 nejm hazard ratio clinical (funded by Novo Nordisk): showed 24% reduction in the risk of disease-related events in people with type 2 diabetes and chronic kidney disease compared to placebo. Investigators Liraglutide and Renal Outcomes in
Description
Rybelsus k thut dng: Sng sm khi i
Strength training supports mental health too Many people start GLP-1 medication to address physical health concerns, but they often stick with their new habits because of how it makes them feel not just physically, but mentally
I deadlifted and squatted 3x5 (3 sets of 5 reps) about 0.85x my bodyweight, and I could overhead press about 0.3x of it
Constipation, one of the most frequent issues, often leads patients to consider using laxatives for relief
Side Effects and Safety Signals The most likely overlap between these medicines is gastrointestinal tolerability
